Eli Lilly has shown that Jaypirca is as good as, if not better than, Johnson & Johnson and AbbVie’s Imbruvica at shrinking certain types of

Vertex and CRISPR Therapeutics released first data on Monday showing that their landmark gene therapy Casgevy is effective in kids under 12. Casgevy was approved

Kimberly-Clark plans to acquire Kenvue in a deal worth about $48.7 billion in enterprise value. The deal, which was announced Monday morning, brings together the

Facing talc and Tylenol litigation, J&J consumer health spinout Kenvue has agreed to a takeover by consumer goods giant Kimberly-Clark.

UniQure’s stock was in freefall Monday morning after the company announced that it might not be able to submit its Huntington’s disease gene therapy for